ODEVIXIBAT vs OLAPARIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ODEVIXIBAT vs OLAPARIB: Safety Overview
| Metric | ODEVIXIBAT | OLAPARIB |
|---|---|---|
| Total FAERS Reports | 223 | 18,274 |
| Deaths Reported | 10 | 5,496 |
| Death Rate | 4.5% | 30.1% |
| Hospitalizations | 43 | 3,471 |
| Average Patient Age | 14.3 yrs | 62.3 yrs |
| % Female Patients | 49.4% | 79.9% |
| FDA Approval Date | Jul 20, 2021 | Aug 17, 2017 |
| Manufacturer | Albireo Pharma, Inc. | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |